Authors: Korfel, Agnieszka, Elter, Thomas, Thiel, Eckhard, Hänel, Matthias, Möhle, Robert, Schroers, Roland, Reiser, Marcel, Dreyling, Martin, Eucker, Jan, Scholz, Christian, Metzner, Bernd, Röth, Alexander, Birkmann, Josef, Schlegel, Uwe, Martus, Peter, Illerhaus, Gerard, Fischer, Lars
Venue: Haematologica
Type: Publication
Abstract: The prognosis of patients with central nervous system relapse of aggressive lymphoma is very poor with no therapy established so far. In a prospective multicenter phase II study, we evaluated a potentially curative chemotherapy-only regimen in these patients. Adult immunocompetent patients 65 years of age or under received induction chemotherapy with MTX/IFO/DEP (methotrexate 4 g/m(2) intravenously (i.v.) Day 1, ifosfamide 2 g/m(2) i.v. Days 3- 5 and liposomal cytarabine 50 mg intrathecally (i.th) Day 6) and AraC/TT/DEP (cytarabine 3g/m(2) i.v....
(read more)
Topics: 
Internal medicine
Gastroenterology
Surgery
Loading (it may take a couple of seconds)...
Loading (it may take a couple of seconds)...